Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other financing activities (2024 - 2025)

Historic Other financing activities for Kura Oncology (KURA) over the last 2 years, with Q2 2025 value amounting to $515000.0.

  • Kura Oncology's Other financing activities fell 8305.92% to $515000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $8.6 million for FY2024, which is 61343.28% up from last year.
  • Kura Oncology's Other financing activities amounted to $515000.0 in Q2 2025, which was down 8305.92% from $143000.0 recorded in Q1 2025.
  • Kura Oncology's 5-year Other financing activities high stood at $3.0 million for Q2 2024, and its period low was $143000.0 during Q1 2025.